ACELYRIN, INC.

📍 Agoura Hills, United States🗓 Founded 2020👥 112 employees💰 Last funded Nov 2021
Biotechnology Research🌐 acelyrin.com
Website LinkedIn
ACELYRIN, INC. (Nasdaq: SLRN) is a Los Angeles area-based late-stage clinical biopharma company – with additional operations in the San Francisco Bay area – focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising product candidates. ACELYRIN is embedding a corporate culture of Courageous Caring™ -- placing patients first and embracing the concept that all of us are better than any one of us -- as we seek to addresses the most basic human needs: to live a productive life free from diseases.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ACELYRIN, INC.?
ACELYRIN, INC. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did ACELYRIN, INC. last raise funding?
The most recent investment in ACELYRIN, INC. recorded on gritt.io was in November 2021.
When was ACELYRIN, INC. founded?
ACELYRIN, INC. was founded in 2020.
What industry is ACELYRIN, INC. in?
ACELYRIN, INC. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ACELYRIN, INC. based?
ACELYRIN, INC. is headquartered in Agoura Hills, United States.